The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
 
Alison Yan Zhang
Honoraria - AstraZeneca
 
Guy C. Toner
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Medivation (Inst); Medivation (Inst)
 
Nicola Jane Lawrence
No Relationships to Disclose
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Tilray (Inst)
Travel, Accommodations, Expenses - Medivation/Pfizer
 
Andrew James Martin
No Relationships to Disclose
 
Kate Ford
No Relationships to Disclose
 
Amanda Gwendolyn Stevanovic
No Relationships to Disclose
 
David Wyld
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Ipsen; Novartis
Research Funding - Ipsen; Novartis
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Euan Thomas Walpole
No Relationships to Disclose
 
Simon Troon
No Relationships to Disclose
 
Fritha J. Hanning
Employment - Canopy Cancer Care
Leadership - Canopy Cancer Care
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Roche
 
Girish Mallesara
No Relationships to Disclose
 
Andrew James Weickhardt
Honoraria - Eisai; Ipsen
Speakers' Bureau - Astellas Pharma
Research Funding - Merck
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Alison Jane Birtle
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer Schering Pharma; Janssen Oncology; Roche; Sanofi
 
Ian D. Davis
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Eisai (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.
 
Peter S. Grimison
Research Funding - ASLAN Pharmaceuticals (Inst); Boston Biomedical (Inst); Gilead Sciences (Inst); Halozyme (Inst); Medimmune; MSD (Inst); Pfizer (Inst); Pfizer (Inst); Specialised Therapeutics; Tigermed (Inst); Tilray (Inst); Zucero Therapeutics